港股异动 | 先健科技(01302)尾盘涨超4% CS支架系统进入创新医疗器械特别审查程序

智通财经01-21

智通财经APP获悉，先健科技(01302)尾盘涨超4%，截至发稿，涨4.07%，报1.79港元，成交额3776.46万港元。消息面上，1月9日，由国家心血管病中心中国医学科学院阜外医院舒畅教授与先健科技联合研发的Concave Supra一体式弓部三分支重建系统通过国家药品监督管理局批准，进入创新医疗器械特别审查程序，即国家创新“绿色通道”。据悉，CS支架系统是先健第17款获批进入国家创新“...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2605176757?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-21 15:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605176757","market":"sh","top_or_hot":-1,"title":"港股异动 | 先健科技(01302)尾盘涨超4% CS支架系统进入创新医疗器械特别审查程序","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，先健科技(01302)尾盘涨超4%，截至发稿，涨4.07%，报1.79港元，成交额3776.46万港元。消息面上，1月9日，由国家心血管病中心中国医学科学院阜外医院舒畅教授与先健科技联合研发的Concave Supra一体式弓部三分支重建系统通过国家药品监督管理局批准，进入创新医疗器械特别审查程序，即国家创新“绿色通道”。据悉，CS支架系统是先健第17款获批进入国家创新“...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1395555.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 先健科技(01302)尾盘涨超4% CS支架系统进入创新医疗器械特别审查程序</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 先健科技(01302)尾盘涨超4% CS支架系统进入创新医疗器械特别审查程序\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-21 15:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1395555.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，先健科技(01302)尾盘涨超4%，截至发稿，涨4.07%，报1.79港元，成交额3776.46万港元。消息面上，1月9日，由国家心血管病中心中国医学科学院阜外医院舒畅教授与先健科技联合研发的Concave Supra一体式弓部三分支重建系统通过国家药品监督管理局批准，进入创新医疗器械特别审查程序，即国家创新“绿色通道”。据悉，CS支架系统是先健第17款获批进入国家创新“...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1395555.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02800","symbol_name":"盈富基金","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1395555.html","article_id":"2605176757","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605176757","pubTimestamp":1768981051,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，先健科技尾盘涨超4%，截至发稿，涨4.07%，报1.79港元，成交额3776.46万港元。消息面上，1月9日，由国家心血管病中心中国医学科学院阜外医院舒畅教授与先健科技联合研发的Concave Supra一体式弓部三分支重建系统通过国家药品监督管理局批准，进入创新医疗器械特别审查程序，即国家创新“绿色通道”。据悉，CS支架系统是先健第17款获批进入国家创新“绿色通道”的自主原研创新产品。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","02800":"盈富基金","BK1583":"高瓴概念","BK1100":"医疗保健设备","01302":"先健科技","BK1610":"ETF&股票定投概念","09996":"沛嘉医疗-B","BK1600":"工业大麻","BK1574":"生物医药B类股","BK1222":"医疗保健用品","09997":"康基医疗"},"translate_title":"Changes in Hong Kong stocks | Lifetech (01302) rose more than 4% in late trading, CS stent system entered special review process for innovative medical devices","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1.5,"01302":1.5,"02800":1.5,"09997":1.5,"09996":1.5},"content_text":"智通财经APP获悉，先健科技(01302)尾盘涨超4%，截至发稿，涨4.07%，报1.79港元，成交额3776.46万港元。消息面上，1月9日，由国家心血管病中心中国医学科学院阜外医院舒畅教授与先健科技联合研发的Concave Supra一体式弓部三分支重建系统通过国家药品监督管理局批准，进入创新医疗器械特别审查程序，即国家创新“绿色通道”。据悉，CS支架系统是先健第17款获批进入国家创新“绿色通道”的自主原研创新产品。公开资料显示，该产品适用于复杂主动脉弓部动脉瘤及穿透性溃疡的微创治疗，为全球首创无脑缺血一体式弓部三分支重建解决方案。该产品将与主动脉弓部分支重建烟囱技术创新产品矩阵、主动脉弓部分支重建原位开窗技术创新产品矩阵及SureCham单分支支架系统共同构成先健独特的主动脉弓部病变腔内治疗整体解决方案。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605176757","isCrawlerRequest":true}